Skip to main content

December 2015

 

 

academics

 

Clinical research courses

 In a good news for those who cannot shun their drink and also have "sweet tooth", scientists have discovered for the first time a liver hormone that works via brain to reduce cravings for sweets and alcohol in mammals.

(adsbygoogle = window.adsbygoogle || []).push({});
Career as Medical Representative (22 posts) at KAPL - Government Enterprise

Karnataka Antibiotics & Pharmaceuticals Ltd., (KAPL) Bangalore is a Government Enterprise.  From a modest beginning in 1984, KAPL has grown from strength to strength in the areas of manufacturing and marketing of various life saving and essential drugs. With an ISO accredition from KPMG, Netherlands, KAPL is recognised for its total commitment to quality and services in domestic and international markets. On profit from inception, KAPL facilities are approved by many international clients.

Opening for Professor, Assistant Professor, Associate Professor in department of Pharmacy at NIET

Noida Institute of Engineering and Technology, a self financed Institute offering high standard quality education to students from all corners of the country is situated in Greater Noida (a hub of global MNCs). It was established by eminent visionaries, responsible for setting up City Educational & Social Welfare Society of Meerut, with a vision to provide value driven education of global dimensions.

Post: Faculty positions

Walk in interview for various posts at Gouri devi institute of Medical sciences & hospital durgapur

The Rahul Foundation, established by R.N Majumder an enlightened industrialist, is a registered trust committed to provide quality higher education. It is geared to meet the challenges thrown up by the globalization.

With annual consumption of 30 billion units of various generic medicines, Iran, the second-biggest consumer of generics in the Asian continent spent over USD 4.5 billion on drugs in 2015. While per capita consumption of generic drugs is three times higher than average per capita consumption in the world, biological medicines and drugs for special diseases suffers from limited access. Cardiovascular, Anti-Cancer & chemotherapy drugs, MAB, pain relievers & Hydrocortisones, Anti infections, Plasma products & Recombinants as well as Diabetes control over 55% of the total sales market. Solid dose (Tablet &Capsules) and injection forms control 42% and 38% of total sales market, respectively.

Biocon Ltd, Asia's premier biotechnology company, introduces an advanced novel therapy CIMIVIR-L™ for the treatment of Hepatitis C in India. CIMIVIR-L™ is a fixed dose combination of Ledipasvir 90 mg and Sofosbuvir 400 mg, which is an equivalent of  the innovator product commercialized by Gilead Sciences in the US.